-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H41QB59+lMoQ0zWYjz48H9tbpNpTcME773csu9vMS4O3j5l42gasrP2FhXw+sItU 1fgZa1rXYIGyT8/6BLeZQw== 0001068878-05-000006.txt : 20050611 0001068878-05-000006.hdr.sgml : 20050611 20050602131014 ACCESSION NUMBER: 0001068878-05-000006 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050602 DATE AS OF CHANGE: 20050602 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SERACARE LIFE SCIENCES INC CENTRAL INDEX KEY: 0001156295 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330056054 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62043 FILM NUMBER: 05873029 BUSINESS ADDRESS: STREET 1: 1935 AVENIDA DEL ORO STREET 2: SUITE F CITY: OCEANSIDE STATE: CA ZIP: 92056 BUSINESS PHONE: 7608068922 MAIL ADDRESS: STREET 1: 1935 AVENIDA DEL ORO STREET 2: SUITE F CITY: OCEANSIDE STATE: CA ZIP: 92056 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PECKS MANAGEMENT PARTNERS LTD CENTRAL INDEX KEY: 0001068878 IRS NUMBER: 113015963 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE ROCKEFELLER PLAZA STREET 2: STE 900 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2123321333 MAIL ADDRESS: STREET 1: ONE ROCKEFELLER PLAZA STREET 2: STE 900 CITY: NEW YORK STATE: NY ZIP: 10020 SC 13G/A 1 sera13g53105.txt SERACARE LIFE SCIENCES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) SeraCare Life Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 81747Q100 (CUSIP Number) May 31, 2005 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 81747Q100 13G Page 2 of 3 Pages 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Pecks Management Partners Ltd. 11-3015963 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) Not applicable 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York 5 SOLE VOTING POWER 1,142,438 6 SHARED VOTING POWER Not applicable 7 SOLE DISPOSITIVE POWER 1,142,038 8 SHARED DISPOSITIVE POWER Not applicable 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,142,038 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] Not applicable 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.5% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA PAGE 3 OF 3 PECKS MANAGEMENT PARTNERS LTD. Item 1a. SeraCare Life Sciences, Inc. Item 1b 1935 Avenida Del Oro Suite F Oceanside, CA 92056 Item 2a Pecks Management Partners Ltd. Item 2b One Rockefeller Plaza, Suite 1730 New York, NY 10020 Item 2c New York Item 2d Common Stock Item 2e CUSIP: 81747Q100 Item 3e Investment Adviser Registered under Section 203 of the Investment Advisers Act of 1940 Item 4 a 1,142,038 b 8.5% ci 1,142,038 ii Not Applicable iii 1,142,038 iv Not Applicable Item 5 Not applicable Items 6 The Common Stock as to which this Schedule relates are owned by four (4) investment advisory clients of Pecks, which clients would received dividends and the proceeds from the sale of such shares. One such client, Delaware State Employees Retirement Fund, is known to have such interest with respect to more than 5% of the class. Item 7-9 Not applicable Item 10 By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth is true, complete and correct. June 1, 2005 ______________________________ Robert J. Cresci Principal -----END PRIVACY-ENHANCED MESSAGE-----